SCHEMBL2423746

SCHEMBL2423746

NC(=O)c1ccccc1CC1CCCNC1

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 3/20 0.52
EED O75530 3/20 0.50
CHRNB2 P17787 3/20 0.49
CHRNA4 P43681 3/20 0.49
CHRNB4 P30926 2/20 0.49
CHRNA3 P32297 2/20 0.49
KMT2A Q03164 1/20 0.49
AURKA O14965 2/20 0.44
RPS6KB1 P23443 2/20 0.44
SLC6A2 P23975 1/20 0.44
SLC6A4 P31645 1/20 0.44
SLC6A3 Q01959 1/20 0.44
IKBKB O14920 1/20 0.43
CHUK O15111 1/20 0.43
CSF1R P07333 1/20 0.43
BTK Q06187 1/20 0.43
IRAK4 Q9NWZ3 5/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28238727 1.00 PARP1 (0.52) PARP1EEDCHRNB2CHRNA4CHRNB4
SCHEMBL29818185 0.84 TP53 (0.43) KMT2ASLC6A2SLC6A4SLC6A3
SCHEMBL9996739 0.84 TP53 (0.47) KMT2A
SCHEMBL3330911 0.82 AURKA (0.49) PARP1AURKARPS6KB1SLC6A2SLC6A4
SCHEMBL4707109 0.82 TP53 (0.49) KMT2A
Hydrochloric Acid SCHEMBL28243996 0.81 AURKA (0.48) PARP1AURKARPS6KB1SLC6A2SLC6A4
SCHEMBL818681 0.81 EED (0.50) PARP1EEDCHRNB2CHRNA4CHRNB4
SCHEMBL2303340 0.80 KDM4E (0.44) KMT2A
SCHEMBL29373827 0.79 GRIK1 (0.40) PARP1KMT2ASLC6A2SLC6A4SLC6A3
SCHEMBL30172061 0.79 PARP1 (0.43) PARP1AURKARPS6KB1IRAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3898631-A1 NOVEL IMIDAZOPYRAZINE DERIVATIVES AS ANTIBACTERIALS F. Hoffmann-La Roche AG (CH) 2021-10-27 EP claimed
WO-2020126953-A1 NOVEL IMIDAZOPYRAZINE DERIVATIVES AS ANTIBACTERIALS F. HOFFMANN-LA ROCHE AG (CH) 2020-06-25 WO claimed
WO-2011117254-A1 PIPERIDINE AMIDES AS MODULATORS OF THE GHRELIN RECEPTOR PROSIDION LIMITED (GB) 2011-09-29 WO disclosed
EP-1399160-A4 NR2B RECEPTOR ANTAGONISTS FOR THE TREATMENT OR PREVENTION OF MIGRAINES MERCK & CO INC (US) 2004-08-25 EP disclosed
EP-1399160-A2 NR2B RECEPTOR ANTAGONISTS FOR THE TREATMENT OR PREVENTION OF MIGRAINES Merck & Co., Inc. (US) 2004-03-24 EP disclosed
WO-2002100352-A2 NR2B RECEPTOR ANTAGONISTS FOR THE TREATMENT OR PREVENTION OF MIGRAINES MERCK & CO., INC. (US) 2002-12-19 WO disclosed